Skip to contentM
Mesa Laboratories Inc
M
MLABMesa Laboratories Inc Q4 2025 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$62.14M$62.14Mderived+5.5% vs Q4 2024 Net Income-$7.11M-$7.11MderivedN/M vs Q4 2024 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Mesa Laboratories Inc · CIK 724004 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$38,412,000+5.1% Operating Incomederived$1,469,000N/M Operating Cash Flowderived$12,665,000−1.7% Free Cash Flowderived$11,908,000−3.6% Margins · derivedGross margin61.8%−0.2 pt vs Q4 2024
Operating margin2.4%+462.9 pt vs Q4 2024
Net margin-11.4%+420.8 pt vs Q4 2024
ended Mar 31, 2025 · filed May 28, 2025 · 58 d after period end